Lilly’s older Alzheimer’s drug fails to prevent disease in trial
Eli Lilly said the study concludes its clinical development of solanezumab, apparently shutting the door on one of the most closely watched experimental drugs over the past decade.
John Russell
Articles
In ninth try, Eli Lilly asks shareholders to end staggered terms for board members
The Weinberg Center for Corporate Governance at the University of Delaware, a leading voice for responsible corporate leadership, has generally supported the elimination of staggered terms, saying they can lead to entrenched boards and management that fails to perform.
Investors wary as Elanco pins hopes on new products
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
Under growing pressure, Lilly to cut price of popular insulins by 70%
The Indianapolis-based drugmaker also said it will expand a program that caps patient out-of-pocket costs at $35 or less a month.
IU School of Medicine lands $215M in NIH funding, just shy of another record
Five of the top 10 research studies that received the most NIH funding at the medical school were for Alzheimer’s disease or brain aging, one of the school’s top priorities.
IU Health’s operating income falls 25%, squeezed by labor shortage, rising expenses
IU Health said it responded to its highest patient demand ever last year, driven by surges in COVID-19 cases, high counts of critically ill patients, and the need to perform surgeries and other procedures delayed in the pandemic.
Elanco shares fall 12% on disappointing revenue outlook
The Greenfield-based maker of animal medicines said fourth-quarter revenue fell due to “environmental and competitive pressure” and could continue to slip this year.
After 3 years and 500 court filings, Community Health and feds still wrangling over false-claims allegations
In January 2020, the federal government filed a lawsuit against Community Health Network, alleging the system engaged in a years-long scheme to recruit physicians and pay them huge salaries and bonuses in return for referrals. The two sides are still battling in court.
Tale of two downtowns: $9B set to be invested in projects, even as business district struggles with recovery
Many parts of downtown are thriving—particularly neighborhoods, where rents are rising, people have to stand in line for a lunch table, and investments are flowing. Other parts—especially downtown’s central core, where many workers might come to the office only once or twice a week—are limping along, pockmarked by vacant storefronts, panhandlers and crumbling sidewalks.
Downtown’s largest employers bet on hybrid work
Cummins, Rolls-Royce, Eli Lilly and Co., AES and Elevance Health are among the city’s largest downtown employers and all say most of their workers have the option of working at home at least part of the time.
BioCrossroads CEO Martin to step down in April
Patty Martin, president and CEO of BioCrossroads since 2019, said she plans to leave the organization to examine opportunities in the private sector.
Medical-device company to raise about $15M in IPO
Neuraxis Inc., based in Versailles and with an office in Carmel, said it will use the proceeds to ramp up its sales and marketing efforts, along with research and development and other functions.
IU School of Medicine receives grant to study life-threatening heart defects in newborns
Researchers at Indiana University School of Medicine are hoping to gain new insights into the defect, called coarctation of the aorta, or narrowing of the aorta that obstructs blood flow to vital organs.
Doctors ask lawmakers to free them from noncompete agreements
The Legislature is considering a bill that put Indiana on a list of more than a dozen other states that expressly prohibit or sharply limit non-compete agreements for physicians and other patient-care professionals.
Three years into pandemic, Indiana hospitals paint bleak financial picture
Hospitals across the state experienced their most difficult financial year in 2022 since the beginning of the pandemic, according to a study released Wednesday by the Indiana Hospital Association.
Indiana to get $66.5M to settle overpayment suit against insurer Centene
The settlement with St. Louis-based health insurer Centene Corp. resolves allegations that the company overcharged Indiana’s Medicaid program for pharmaceutical costs.
IU medical school lands $1.25M for increasing diversity
The money will be used to provide new opportunities for graduate students typically underrepresented in biomedical science, officials said.
More big donors want to be anonymous
Some public interest groups say the rising tide of anonymous gifts to not-for-profits can lead to potential fraud or dark-money abuses, so the groups have pushed to require institutions to list their big givers.
Indiana Senate panel advances bill to prohibit non-compete agreements for physicians
It’s the latest in a series of bills meant to address the high cost of health care in Indiana, as well as the physician shortage and patients’ rights.
Lilly to invest another $450M in North Carolina factory
The move will create at least 100 new jobs at the plant, located in Research Triangle Park, the largest research park in the country.